Simplex Trading’s Elevation Oncology ELEV Stock Holding History

Simplex Trading’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,000	Closed	-$14K	–	8766
2024 Q3	$14K	Buy	+25,000	New	+$37.1K	﹤0.01%	6940

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's ELEV Position: Q3 2025 in Review

Simplex Trading sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 22,784 shares — an estimated $8K sold.

Simplex Trading first reported a position in ELEV in Q2 2024 and held it in 4 quarters. The position peaked at $11K in Q3 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Simplex Trading reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 22,784 Elevation Oncology shares in Q3 2025, an estimated $8K.
Simplex Trading first reported a position in Elevation Oncology in Q2 2024 and held it in 4 quarters.
Simplex Trading's Elevation Oncology position peaked at $11K in Q3 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.